穿通静脉消融后静脉性溃疡完全愈合不依赖治疗方式
该多中心回顾性研究纳入232例接受穿通静脉(IPV)消融的静脉性溃疡(VLU)患者,比较激光、射频和泡沫硬化剂三种方式。结果显示三组1年愈合率无差异(P=0.18),后续手术次数也无差异(P=0.47)。
要点
- IPV消融方式(EVLT、RFA、UGFS)不影响VLU的1年愈合率。
- 不同消融方式后续手术次数无显著差异。
- RFA组患者年龄更大、男性更多、抗凝比例更高。
核心结论
- 穿通静脉消融方式与静脉性溃疡愈合率及后续手术次数无关。
研究设计与样本
- 多中心回顾性队列研究,纳入11个医疗中心2013-2017年接受IPV治疗的232例VLU成人患者。
主要发现
- 三组1年溃疡愈合率无差异(P=0.18)。
- 后续手术次数无差异(P=0.47)。
- RFA组年龄更大(62±14岁 vs EVLT 59±14岁 vs UGFS 52±9岁,P=0.01)。
- RFA组男性比例更高(68% vs 41% vs 64%,P<0.001)。
- RFA组抗凝比例更高(36% vs 18% vs 14%,P=0.005)。
临床怎么用
- 选择IPV消融方式时可依据患者特征和设备条件,无需担心愈合率差异。
局限性
- 回顾性设计,样本量有限,UGFS组仅14例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous leg ulceration (VLU) represents the most advanced form of chronic venous insufficiency (CVI). Persistent VLU that fails to respond to noninvasive treatment requires a minimally invasive endovascular treatment, which may include chemical (ultrasound-guided foam sclerotherapy [UGFS]) and thermal ablation (endovenous laser therapy [EVLT] or radiofrequency ablation [RFA]) targeting incompetent veins. Current guidelines suggest ablation of incompetent perforating veins (IPVs) juxtaposed to active or healed VLU; however, the ideal treatment modality is unknown. We hypothesize that similar to incompetent superficial vein treatment options therapies, VLU healing will be equivalent across minimally invasive IPV treatment options. METHODS: Using the Vascular Low Frequency Disease Consortium, adults with VLU across 11 medical centers were retrospectively reviewed (2013-2017). We included those who underwent IPV therapies. The primary outcome was complete ulcer healing over time compared with cumulative hazard curves, log-rank testing, and multivariable Cox proportional hazard regression. Secondary outcomes included number of subsequent procedures, which were compared using negative binomial regression. RESULTS: Of the 832 adults with VLU, 158 (19%) were exclusively treated conservatively, and 232 (28%) underwent index treatment for IPV and constitute the full and final cohort. The mean age was 60 ± 14 years, 57% were men, and the mean ulcer area was 3.0 cm2 (interquartile range, 1-6 cm2). Ninety-one (39%) were treated with EVLT, 127 (55%) RFA, and 14 (6%) UGFS. Patients treated with RFA were older (RFA 62 ± 14 years; EVLT 59 ± 14 years; UGFS 52 ± 9 years; P = 0.01), more likely to be men (RFA 68%, n = 86; EVLT 41%, n = 37; UGFS 64%, n = 9; P < 0.001), with a higher frequency of anticoagulation (RFA 36%, n = 46; EVLT 18%, n = 16; UGFS 14%, n = 2; P = 0.005). VLU did not significantly differ in size between groups (RFA 6.2 ± 8; EVLT 4.2 ± 5.4; UGFS 6.1 ± 8; P < 0.001). There were no differences in 1-year ulcer healing rates between groups (P = 0.18). The number of subsequent procedures did not differ by treatment modality (P = 0.47). CONCLUSIONS: This multi-institutional retrospective study does not demonstrate any association of IPV treatment modality with differing rates of VLU healing or number of subsequent procedures.
引用
- Reitz KM, Salem K, Mohapatra A, et al. Complete Venous Ulceration Healing after Perforator Ablation Does Not Depend on Treatment Modality. Ann Vasc Surg. 2020. PMID: 32603845. doi:10.1016/j.avsg.2020.06.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。